Effect of probenecid on 5-hydroxyindoles in cerebrospinal fluid in Down's syndrome.
D000284:Administration, Oral; D000293:Adolescent; D002648:Child; D002850:Chromatography, Gel; D003864:Depression, Chemical; D004314:Down Syndrome / Q000134:cerebrospinal fluid*; D005260:Female; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid*; D008607:Intellectual Disability / Q000134:cerebrospinal fluid; D007361:Intelligence Tests; D008297:Male; D011339:Probenecid / Q000008:administration & dosage / Q000134:cerebrospinal fluid / Q000494:pharmacology*; D013050:Spectrometry, Fluorescence; D013997:Time Factors
D006897:Hydroxyindoleacetic Acid; D011339:Probenecid